Infinity Pharmaceuticals (NASDAQ:INFI) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Free Report) in a report released on Saturday. The firm set a “hold” rating on the biotechnology company’s stock. Infinity Pharmaceuticals Stock Performance INFI opened at $0.21 on Friday. The firm has a market cap of $18.93 million, a P/E ratio of […]

Related Keywords

,Infinity Pharmaceuticals Stock Performance ,Virtu Financial ,Wittenberg Investment Management Inc ,Infinity Pharmaceuticals Inc ,Mirabella Financial Services ,Infinity Pharmaceuticals ,News Ratings For Infinity Pharmaceuticals Daily ,Hedge Funds Weigh In On Infinity Pharmaceuticals ,Infinity Pharmaceuticals Company Profile ,Free Report ,Sigma Investments ,Investment Management ,Financial Services ,Jane Street Group ,Infinity Pharmaceuticals Daily ,